Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Lane

Showing results (91-100 of 265) with videos related to

Pageof 27
Sort By:
British Journal of Haematology|May 1, 1983
Fibrinogen Manchester: identification of an abnormal fibrinopeptide A with a C-terminal arginine leads to histidine substitutionC Southan, M Kehl, A Henschen, et al.
Thrombosis and Haemostasis|August 24, 1982
In vivo platelet release in myeloproliferative disordersH Ireland, D A Lane, S Wolff, et al.
Nucleic Acids Research|September 1, 1994
Antithrombin III: summary of first database updateD A Lane, R J Olds, S L Thein
The Cochrane Database of Systematic Reviews|January 28, 2005
Psychological interventions for depression in heart failureD A Lane, A Y Chong, G Y H Lip
Blood|December 1, 1996
Identification of 19 protein S gene mutations in patients with phenotypic protein S deficiency and thrombosis. Protein S Study GroupR E Simmonds, H Ireland, G Kunz, et al.
QJM : Monthly Journal of the Association of Physicians|June 15, 2007
Ethnic differences in cancer incidence and mortality: the Birmingham Factory Screening ProjectD A Lane, G Y H Lip, D G Beevers
Heart (British Cardiac Society)|June 18, 2002
Quality of life in adults with congenital heart diseaseD A Lane, G Y H Lip, T A Millane
Biochemistry|July 20, 1993
Heparin binding affinity of normal and genetically modified antithrombin III measured using a monoclonal antibody to the heparin binding site of antithrombin IIIJ Watton, C Longstaff, D A Lane, et al.
British Journal of Haematology|March 1, 1980
Dysfibrinogenaemia characterized by abnormal fibrin monomer polymerization and normal fibrinopeptide A releaseD A Lane, B Cuddigan, M VanRoss, et al.
British Journal of Haematology|June 1, 1995
An ELISA for factor X activation peptide: application to the investigation of thrombogenesis in cardiopulmonary bypassH Philippou, A Adami, M D Boisclair, et al.
Pageof 27

Showing results (91-100 of 265) with videos related to

Sort By:
Pageof 27
British Journal of Haematology|May 1, 1983
Fibrinogen Manchester: identification of an abnormal fibrinopeptide A with a C-terminal arginine leads to histidine substitutionC Southan, M Kehl, A Henschen, et al.
Thrombosis and Haemostasis|August 24, 1982
In vivo platelet release in myeloproliferative disordersH Ireland, D A Lane, S Wolff, et al.
Nucleic Acids Research|September 1, 1994
Antithrombin III: summary of first database updateD A Lane, R J Olds, S L Thein
The Cochrane Database of Systematic Reviews|January 28, 2005
Psychological interventions for depression in heart failureD A Lane, A Y Chong, G Y H Lip
Blood|December 1, 1996
Identification of 19 protein S gene mutations in patients with phenotypic protein S deficiency and thrombosis. Protein S Study GroupR E Simmonds, H Ireland, G Kunz, et al.
QJM : Monthly Journal of the Association of Physicians|June 15, 2007
Ethnic differences in cancer incidence and mortality: the Birmingham Factory Screening ProjectD A Lane, G Y H Lip, D G Beevers
Heart (British Cardiac Society)|June 18, 2002
Quality of life in adults with congenital heart diseaseD A Lane, G Y H Lip, T A Millane
Biochemistry|July 20, 1993
Heparin binding affinity of normal and genetically modified antithrombin III measured using a monoclonal antibody to the heparin binding site of antithrombin IIIJ Watton, C Longstaff, D A Lane, et al.
British Journal of Haematology|March 1, 1980
Dysfibrinogenaemia characterized by abnormal fibrin monomer polymerization and normal fibrinopeptide A releaseD A Lane, B Cuddigan, M VanRoss, et al.
British Journal of Haematology|June 1, 1995
An ELISA for factor X activation peptide: application to the investigation of thrombogenesis in cardiopulmonary bypassH Philippou, A Adami, M D Boisclair, et al.
Pageof 27